pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7- (2-methyl-6- (1h-1,2,4-triazol-3-yl) pyridin-3-yl) -3, 4-dihydropyrazine [2,3-b] pyrazine-2 (1h) -one
Anil MENON,Benjamin COHEN,Darshan K. PARIKH,Dora VISKY,Jean XU,Matthew Michael KREILEIN,Nathan BOERSEN,THOMAS LEE,William Wei-Hwa LEONG,Xiaozhang LIANG,Ying LI
申请号：
BR112015026300
公开号：
BR112015026300A2
申请日:
2014.04.16
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
summary pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7- (2-methyl-6- (1h-1,2,4-triazol-3-yl) pyridin-3-yl) -3 4,4-Dihydropyrazine [2,3-b] pyrazine-2 (1h) -one There are provided formulations, processes, solid forms and methods of use relating to 1-ethyl-7- (2-methyl-6- (1h- 1,2,4-triazol-3-yl) pyridin-3-yl) -3,4-dihydropyrazine [2,3-b] pyrazin-2 (1h) -one. 1/1resumo formulações farmacêuticas, processos, formas sólidos e métodos de uso relativas a 1-etil-7-(2-metil-6-(1h-1,2,4-triazol-3-il)piridina-3-il)-3,4-dihidropirazina[2,3-b] pirazina-2(1h)-ona aqui são proporcionados formulações, processos, formas sólidas e métodos de utilização relativos a 1-etil-7-(2-metilo-6-(1h-1,2,4-triazol-3-il)piridina-3-il)-3,4-dihidropirazina[2,3-b] pirazina-2(1h)-ona. 1/1
